Recruiting NA INTERVENTIONAL 3-arm NCT05297773

Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment (NEO-Program)

Effects of Resistance vs. Aerobic Training on Ki-67 and Other Health-Related Biomarkers: The NEO-Program, a Randomized Controlled Trial on Breast Cancer Patients Undergoing Neoadjuvant Treatment

Sponsor: Faculdade de Motricidade Humana - Universidade de Lisboa

Conditions Breast Cancer

Interventions Aerobic Training Group Control group Resistance Training Group

Updated 8 times since 2022 Last updated: Feb 24, 2025 Started: Dec 16, 2022 Primary completion: Dec 30, 2025 Completion: Dec 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Breast Cancer, this trial is actively recruiting participants. The trial is conducted by Faculdade de Motricidade Humana - Universidade de Lisboa and has accumulated 8 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Recruiting NA
Jun 2025 — Sep 2025 [monthly]

Recruiting NA
Mar 2025 — Jun 2025 [monthly]

Recruiting NA
Sep 2024 — Mar 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Mar 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2022 — Mar 2023 [monthly]

Not Yet Recruiting NA
Apr 2022 — Sep 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Faculdade de Motricidade Humana - Universidade de Lisboa
Fundacao Champalimaud

Data source: Fundacao Champalimaud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal